about
Stress, dysregulation of drug reward pathways, and the transition to drug dependenceCortisol Stress Response in Men and Women Modulated Differentially by the Mu-Opioid Receptor Gene Polymorphism OPRM1 A118G.Multiple actions of spinophilin regulate mu opioid receptor functionLayer selective presynaptic modulation of excitatory inputs to hippocampal cornu Ammon 1 by mu-opioid receptor activationDifferent lengths of times for progressions in adolescent substance involvement.HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuseR7BP modulates opiate analgesia and tolerance but not withdrawal.A unique role of RGS9-2 in the striatum as a positive or negative regulator of opiate analgesiaNaltrexone effects on cortisol secretion in women and men in relation to a family history of alcoholism: studies from the Oklahoma Family Health Patterns Project.Effects of chronic expression of the HIV-induced protein, transactivator of transcription, on circadian activity rhythms in mice, with or without morphineRole of mu- and delta-opioid receptors in the nucleus accumbens in cocaine-seeking behavior.Network-assisted prediction of potential drugs for addiction.Brain region specific actions of regulator of G protein signaling 4 oppose morphine reward and dependence but promote analgesia.The effect of propranolol and midazolam on the reconsolidation of a morphine place preference in chronically treated rats.Analgesic tolerance to morphine is regulated by PPARγ.Memory retrieval in addiction: a role for miR-105-mediated regulation of D1 receptors in mPFC neurons projecting to the basolateral amygdala.Opiate Drugs with Abuse Liability Hijack the Endogenous Opioid System to Disrupt Neuronal and Glial Maturation in the Central Nervous System.Selective blockade of spinal D2DR by levo-corydalmine attenuates morphine tolerance via suppressing PI3K/Akt-MAPK signaling in a MOR-dependent manner
P2860
Q24629577-F3D152C0-9B89-450E-8D69-E3AB87792723Q27311002-C3EABF7D-8145-4196-A7A8-C61260FEC85EQ28512764-AFED36EA-2DB4-4315-B7C6-CE2194ADA894Q28573997-6DB148DD-B589-41C2-8C27-BD58133440B1Q34928953-E21278FF-39F9-441F-9C05-8002B86C39C5Q35009465-481EB7A1-8E7E-4866-B2A4-705E35360A2DQ35760250-E1701484-2629-4A8C-958E-4FAC33314ECFQ36141986-11198B4B-A3FF-4947-8EC2-C5BBC3AA24C3Q36253208-D16273B2-A026-45B0-BE47-BF409E3E2E7BQ36977202-446EA679-0F41-4E6C-B2F8-7DC976EB9DDDQ37252543-8537F65D-BAB3-4C3E-B45B-C06FDA4C43D9Q39218459-E99D7B0A-E4A8-4517-93D1-4D7F954D4418Q42601949-45F210FE-80A0-4593-9040-7E2F3B2315B1Q42853652-74E729D0-AB74-41AE-B157-F687C9E308F8Q43105759-7F7F38CF-E30E-4385-B109-F04BFEE74D62Q47099352-A7EB178A-751F-4211-9769-8DCE0530B450Q49270407-3426BCEA-E221-4228-A8AF-EB1FDA93EAEAQ59131861-815F1C85-E7C8-4AD1-AA19-E846005CA95D
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Drug addictions. Molecular and cellular endpoints.
@ast
Drug addictions. Molecular and cellular endpoints.
@en
Drug addictions. Molecular and cellular endpoints.
@nl
type
label
Drug addictions. Molecular and cellular endpoints.
@ast
Drug addictions. Molecular and cellular endpoints.
@en
Drug addictions. Molecular and cellular endpoints.
@nl
prefLabel
Drug addictions. Molecular and cellular endpoints.
@ast
Drug addictions. Molecular and cellular endpoints.
@en
Drug addictions. Molecular and cellular endpoints.
@nl
P1476
Drug addictions. Molecular and cellular endpoints
@en
P2093
P407
P577
2001-06-01T00:00:00Z